28
▪ Permanent implant in the treated area such as metal plates and screws,
silicone implants or an injected chemical substance, unless deep
enough in the periostal plane.
▪ Current or history of skin cancer, or current condition of any other type
of cancer, or premalignant moles.
▪ Severe concurrent conditions, such as cardiac disorders, epilepsy,
uncontrolled hypertension, and liver or kidney diseases.
▪ Pregnancy and nursing.
▪ Impaired immune system due to immunosuppressive diseases such as
AIDS and HIV, or use of immunosuppressive medications.
▪ Patients with history of diseases stimulated by heat, such as recurrent
Herpes Simplex in the treatment area, may be treated only following a
prophylactic regimen.
▪ Poorly controlled endocrine disorders, such as diabetes or thyroid
dysfunction.
▪ Any active condition in the treatment area, such as sores, psoriasis,
eczema, and rash.
▪ History of skin disorders, keloids, abnormal wound healing, as well as
very dry and fragile skin.
▪ History of bleeding coagulopathies or use of anticoagulants in the last
10 days, according to physician's discretion.
▪ Any surgery in treated area within 6 months prior to treatment.
▪ Intra-dermal or superficial sub-dermal areas that have been injected
with HA/collagen/fat injections or other augmentation methods with
bio-material during last 6 months.
▪ Having received treatment with light, laser, RF, or other devices in the
treated area within 3 months, or before complete healing.
▪ Use of Isotretinoin (Accutane®) within 6 months prior to treatment.
▪ Intra-dermal or superficial sub-dermal areas that have been injected
with HA/collagen/fat injections or other augmentation methods with
bio-material during last 6 months.
▪ Having received treatment with light, laser, RF, or other devices in the
treated area within 3 months, or before complete healing.
▪ As per the practitioner's discretion, refrain from treating any condition
that might make it unsafe for the patient.
To Next Page
Loading...
